The Life Science Washington Board of Directors is comprised of knowledgeable and experienced professionals from the life sciences sector in Washington state. The Board of Directors actively oversees our policies and strategy.
Comprised of members of the Board, the Executive Committee is charged with monthly review of Life Science Washington's financials and strategic direction.
2017 Executive Committee
- Martin Simonetti, CEO | MASx2 Consulting (Chair)
- Leslie Alexandre, DrPH, President & CEO | Life Science Washington (Secretary)
- Caitlin Cameron, CEO | OtoNexus Medical Technologies (Vice Chair)
- Lisa Cohen, Executive Director | WA Global Health Alliance
- Ralph Derrickson, CEO | Carena
- Stephen M. Graham, Partner | Fenwick & West LLP
- Brad Gray, President & CEO | NanoString Technologies, Inc.
- Oren Lang-Furr, Partner | EY
- Thong Q. Le, CEO | Accelerator Corporation
- Margaret McCormick, PhD, CEO | Matrix Genetics (Treasurer)
- Erik Nilsson, CEO | Deurion, LLC
- Gregory Sessler, President & CEO | Spiration
- Francisco R. Velázquez, MD, SM, President & CEO | PAML, LLC and PAML Ventures
Board of Directors
- Susan Ashe, Executive Director | Health Sciences & Services Authority
- Charles V. Baltic III, Managing Director & Co-Head of Life Sciences | Needham & Company, LLC
- Jan Beck, VP & Site Head | Novo Nordisk
- Nicole Bell, Executive Director | Cambia Grove
- Bill Brady, President | Brady & Company
- Thomas Clement, President & CEO | Aqueduct Critical Care
- John Cox, SVP-Seattle | Alexandria Real Estate Equities, Inc.
- Helga Ding, DDS, Managing Director | Group Health Research Institute
- Sonya F. Erickson, Partner | Cooley LLP
- Teresa Foy, PhD, Senior Director | Celgene
- James B. Hendricks, PhD, President | Seattle Children’s Research Institute
- Charlotte Hubbert, PhD, Partner - Gates Foundation Venture Capital | Bill & Melinda Gates Foundation
- Leen Kawas, PharmD & PhD, President & CEO | M3 Biotechnology
- Jary J. Krauser, CEO | StratusG Consulting
- Homer Lane, Executive Director & CFO | Benaroya Research Institute
- Gustavo Mahler, PhD, President & Global COO | CMC Biologics
- Tim Martin, Director of Global Government Affairs | Amgen
- Ron Meyers, CEO | Nexgenia Inc.
- Robert W. Overell, PhD, President & CEO | PhaseRx, Inc.
- Craig W. Philips, COO | KPI Therapeutics
- Jens U. Quistgaard, PhD, Chairman | Mirabilis Medica
- Rhonda Rhyne, President & CEO | Prevencio, Inc.
- Ken Roberts, PhD, Vice Dean of Academic and Community Partnerships | Elson S. Floyd College of Medicine, Washington State University
- Chad Robins, CEO | Adaptive Biotechnologies
- Mike Ruhl, Vice President, Seattle Market Lead | BioMed Realty & Trust
- Randy Schatzman, CEO | Alder BioPharmaceuticals, Inc.
- R. Lee Schindler, Partner | Perkins Coie LLP
- Andrew T. Serafini, PhD, Partner | Kilpatrick Townsend & Stockton LLP
- Todd Simpson, CFO | Seattle Genetics, Inc.
- Ken Stuart, PhD, President & Professor | Center for Infectious Disease Research
- Matt Stupfel, General Manager | EKOS Corporation
- Ronald Thomas, Commercialization Manager | Pacific Northwest National Laboratory Battelle
- John Wecker, PhD, President & CEO | Pacific Northwest Diabetes Research Institute